In the yearlong clinical trial, 165 participants with mild cognitive impairment or dementia from Alzheimer's took either a 1 -, 3 -, 6 -, or 10 - mg / kg dose of aducanumab once a month, or a placebo. (sciencemag.org)
A new antibody drug called aducanumab appears to sweep the brain clean of sticky amyloid - beta protein. (sciencenews.org)
Biotech giant Biogen is hoping to break the curse with an all - in bet on its own experimental treatment aducanumab. (fortune.com)